TDO2 and prostate carcinoma: Additionally, ADT-induced TDO2 upregulation was also observed in another androgen-dependent prostate cancer cell line, VCaP (Fig. 1i), indicating that this phenomenon may be general to androgen-dependent prostate cancers.